Ithaca-area company wins NIH grant funding for HIV/AIDS test
by Eric Reinhardt
Date: 2/12/2015 at 8:29:13
This content is for subscribers only. Please subscribe or login to get full access to the Business Journal News Network.
Click Here for membership choices
LANSING, N.Y. — The National Institutes of Health (NIH) has awarded Rheonix, Inc. a grant to finish development of a point-of-care test for HIV/AIDS.
The small-business innovation research (SBIR) phase II grant from NIH will help the firm complete development of “fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen,” the company announced.